U.S. Healthtech Stock News

NYSE:DAL
NYSE:DALAirlines

A Look At Delta Air Lines (DAL) Valuation After Recent Return Figures And Mixed Pricing Signals

Delta Air Lines stock after recent performance data Delta Air Lines (DAL) has been drawing attention after recent return figures, with the stock near US$71.05 and total return over the past year and the past 3 months offering a fresh reference point for investors. See our latest analysis for Delta Air Lines. Recent trading has been choppy, with a 1-day share price return of 0.48% and a 7-day decline of 3.12%. However, the 30-day share price return of 5.97% and 1-year total shareholder return...
NasdaqGS:CDNS
NasdaqGS:CDNSSoftware

Cadence Design Systems (CDNS) Valuation Check After Aeva 4D LiDAR Licensing And Recent Share Price Momentum

Cadence Design Systems (CDNS) is back on investors’ radar after Aeva licensed its Tensilica Vision DSP IP for 4D LiDAR, coinciding with a recent stock upswing and increasing market interest. See our latest analysis for Cadence Design Systems. The recent Aeva licensing news lands after a strong run in the stock, with a 30-day share price return of 23.02% and a 90-day share price return of 22.97%. The 5-year total shareholder return of 189.85% points to momentum that has been in place for a...
NYSE:ABBV
NYSE:ABBVBiotechs

Assessing AbbVie (ABBV) Valuation After Recent Share Price Pullback And Mixed Performance

What AbbVie’s Recent Performance Tells You AbbVie (ABBV) has drawn investor attention after a mixed recent run in the stock. The share price is around $208.50, and performance has differed sharply between the past month and the past 3 months. Over the past month, AbbVie is up about 1%, while the stock is down roughly 8% over the past 3 months and down about 9% year to date. Even with that pullback, the 1 year total return is about 21%, with 3 year and 5 year total returns of roughly 62% and...
NasdaqGS:CDW
NasdaqGS:CDWElectronic

A Look At CDW (CDW) Valuation After New US$1b Buyback And Solid Q1 Earnings

CDW (CDW) is back in focus after its Board of Directors approved an additional US$1b for share repurchases, following recent first quarter results that included year over year growth in sales and net income. See our latest analysis for CDW. Despite the fresh buyback authorization and recent dividend affirmation, momentum in the stock has been weak, with the share price down 24.6% year to date and the 1 year total shareholder return declining 46.1%. This points to fading sentiment even after...
NYSE:SNX
NYSE:SNXElectronic

TD SYNNEX Expands Cybersecurity Story With Aura Identity BYOD Partnership

TD SYNNEX (NYSE:SNX) has partnered with Aura Business to distribute identity-centric BYOD security solutions across its reseller and MSP network. The collaboration focuses on securing remote and hybrid work setups while maintaining end user privacy. The Aura Business platform will be offered to TD SYNNEX partners as part of its broader cybersecurity and endpoint protection portfolio. For investors tracking TD SYNNEX at a share price of $231.75, this agreement comes during a period of strong...
NasdaqGS:QCOM
NasdaqGS:QCOMSemiconductor

Qualcomm (QCOM) Valuation Check After AI And Data Center Rally Followed By Sharp Semiconductor Pullback

QUALCOMM (QCOM) is back in focus after a sharp swing that started with strong AI and data center headlines, record automotive results, and multiple analyst upgrades, then quickly reversed as chip stocks faced profit taking and hotter inflation data. See our latest analysis for QUALCOMM. That volatility sits on top of powerful recent momentum, with a 30 day share price return of 60.47% and a 90 day share price return of 51.51%. The 1 year total shareholder return stands at 42.96% and the 3...
NYSE:SLB
NYSE:SLBEnergy Services

Assessing SLB (NYSE:SLB) Valuation After Recent Share Price Momentum

Recent performance snapshot for SLB (SLB) SLB (SLB) has drawn attention after a period of solid share price performance, with the stock up about 7% over the past month and roughly 9% over the past 3 months. See our latest analysis for SLB. At a share price of US$55.38, SLB’s recent 7 day gain and 30 day share price return of 6.66% sit alongside a stronger year to date share price return of 37.76%. The 1 year total shareholder return of 58.49% points to momentum that has been building over a...
NasdaqGS:CSGP
NasdaqGS:CSGPReal Estate

A Look At CoStar Group (CSGP) Valuation After Index Exit And Multifamily Construction Slowdown

CoStar Group (CSGP) is back in focus after two developments: the reported collapse in U.S. multifamily construction starts and the company’s upcoming removal from the Nasdaq-100, both carrying different signals for real estate exposure. See our latest analysis for CoStar Group. CoStar Group’s recent news comes against a weak share price backdrop, with the stock at US$31.97 after falling about 14% over the past month and around 51% year to date. The 1 year total shareholder return is down...
NasdaqGS:DDOG
NasdaqGS:DDOGSoftware

Why Datadog (DDOG) Is Up 42.9% After Its First-Ever Billion-Dollar Quarter And Raised 2026 Outlook

In the first quarter of 2026, Datadog, Inc. reported revenue of US$1,006.43 million and net income of US$52.57 million, with diluted EPS of US$0.15 from continuing operations, and issued guidance calling for second-quarter revenue of US$1.07–1.08 billion and full-year 2026 revenue of US$4.30–4.34 billion. The results marked Datadog’s first-ever billion-dollar quarter and were backed by management’s higher full-year outlook, reflecting confidence in growing demand tied to AI-focused workloads...
NYSE:IFF
NYSE:IFFChemicals

IFF Vanilla Hub In Madagascar Ties Origin Sourcing To Undervalued Stock Narrative

IFF (NYSE:IFF) has opened a Vanilla Innovation Center in Madagascar, a key origin for natural vanilla. The facility is intended to focus on origin-based product development, sustainability, and local supply chain support. The center links Madagascar vanilla production with IFF’s broader global vanilla network for food, beverage, and fragrance customers. For investors watching NYSE:IFF, this move sits at the intersection of flavor, fragrance, and consumer demand for traceable, natural...
NasdaqCM:EVLV
NasdaqCM:EVLVElectronic

Evolv Technologies Holdings (EVLV) Q1 Loss Challenges Bullish Profitability Narratives

Evolv Technologies Holdings (EVLV) Q1 2026 earnings snapshot Evolv Technologies Holdings (EVLV) opened 2026 with Q1 revenue of US$46.3 million and a basic EPS loss of US$0.03, as investors weigh those figures against a share price of US$6.02. The company reported quarterly revenue of US$32.0 million in Q1 2025 and US$46.3 million in Q1 2026, while basic EPS moved from a loss of US$0.01 in Q1 2025 to a profit of US$0.06 in Q4 2025 before reverting to a loss this quarter. This keeps the...
NYSE:MAS
NYSE:MASBuilding

Assessing Masco (MAS) Valuation After Recent Choppy Share Performance

Recent Share Performance and Business Scale Masco (MAS) has drawn investor attention after a mixed stretch for the stock, with the price around $67.48 and returns varying between gains over the past month and declines over the past 3 months. The company operates two main segments, Plumbing Products and Decorative Architectural Products, generating revenue of about $7.7b and net income of roughly $837.0m, which gives readers a sense of its current scale. See our latest analysis for...
NasdaqGS:FTAI
NasdaqGS:FTAIAerospace & Defense

A Look At FTAI Aviation (FTAI) Valuation After Strong Q1 2026 Results And Reaffirmed EBITDA Outlook

Why FTAI Aviation’s latest earnings matter for investors FTAI Aviation (FTAI) recently released Q1 2026 results, highlighting execution across its platforms, significant year over year revenue growth, and a reaffirmed full year EBITDA outlook of $1.625b. For you as an investor, those disclosures, together with commentary on demand in Aerospace Products and aviation leasing, help frame the current discussion around FTAI’s earnings power, capital needs, and potential future growth...
NasdaqGS:RVMD
NasdaqGS:RVMDBiotechs

A Look At Revolution Medicines (RVMD) Valuation After FDA Clears Expanded Access To Daraxonrasib

Revolution Medicines (RVMD) is back in focus after the U.S. Food and Drug Administration issued a “safe to proceed” letter for expanded access to its investigational pancreatic cancer therapy, daraxonrasib, for eligible U.S. patients. See our latest analysis for Revolution Medicines. The FDA’s expanded access decision comes after a busy period for Revolution Medicines, with the stock’s 30-day share price return of 10.01% and 90-day share price return of 54.05% pointing to strong momentum. The...
NYSE:ENOV
NYSE:ENOVMedical Equipment

Enovis (ENOV) Valuation Check After Reaffirmed 2026 Guidance And Solid First Quarter Results

Enovis (ENOV) is back on investors' radar after reaffirming its 2026 revenue guidance of about US$2.31b to US$2.37b and posting first quarter sales of US$589.15m, along with a smaller net loss. See our latest analysis for Enovis. Despite the reaffirmed 2026 guidance and first quarter update, the share price is around US$25.70, with a 90 day share price return of 17.3% but a 1 year total shareholder return that declined 29.0%. This suggests recent momentum following a tougher period. If you...
NasdaqGS:LULU
NasdaqGS:LULULuxury

A Look At Lululemon Athletica (LULU) Valuation After A Steep Share Price Pullback

Stock performance snapshot after recent pullback lululemon athletica (LULU) has been under pressure, with the stock down about 3% over the past day, 8% over the past week and 25% over the past month, extending a weaker past 3 months. Over the year to date the stock is down about 43%, and over the past year the total return is down about 62%, giving investors a very different experience than in prior years, despite the company reporting annual revenue of US$11.10b and net income of...
NYSE:NCLH
NYSE:NCLHHospitality

A Look At Norwegian Cruise Line (NCLH) Valuation After The Recent Share Price Slide

Recent share performance and what it might signal Norwegian Cruise Line Holdings (NCLH) stock has fallen about 21% over the past month and roughly 31% over the past 3 months, prompting investors to reassess the company’s current valuation and risk profile. See our latest analysis for Norwegian Cruise Line Holdings. The recent share price slide, including a 9.5% decline over the last week and a 29.5% year to date share price decline to US$16.06, contrasts with a 3 year total shareholder return...
NYSE:PLOW
NYSE:PLOWMachinery

What Douglas Dynamics (PLOW)'s Upgraded 2026 Outlook and Buyback Completion Means For Shareholders

Earlier in May 2026, Douglas Dynamics reported first-quarter 2026 sales of US$137.8 million and net income of US$6.38 million, raised its full‑year 2026 net sales guidance to US$750 million–US$795 million, completed a US$15 million buyback program covering 451,523 shares, and obtained stockholder approval to add officer exculpation to its Delaware charter. Management also reaffirmed its focus on acquisitions following the Venco Venturo purchase, signaling an intent to use its...
NasdaqGS:STLD
NasdaqGS:STLDMetals and Mining

Assessing Steel Dynamics (STLD) Valuation After Strong Recent Share Price Momentum

What Steel Dynamics’ Recent Performance Signals for Investors Steel Dynamics (STLD) has drawn investor attention after its stock logged a 21.3% gain over the past month and a 79.7% total return over the past year, prompting fresh interest in its current valuation. See our latest analysis for Steel Dynamics. The recent 30 day share price return of 21.3% and year to date share price return of 34.7% sit alongside a 1 year total shareholder return of 79.7% and 5 year total shareholder return of...
NYSE:AXP
NYSE:AXPConsumer Finance

Is It Time To Reassess American Express (AXP) After Its Recent Share Price Pullback

If you are wondering whether American Express stock still offers value after its long run, this section will help you line up the current price with what the underlying business may be worth. The stock closed at US$309.61, with returns that are down 3.8% over the past week, down 4.4% over the past month, down 16.9% year to date, but still up 4.3% over the past year and more than doubling over both the past 3 and 5 years. Recent headlines around American Express have centered on its position...
NasdaqGS:INTR
NasdaqGS:INTRBanks

Inter & Co (INTR) Is Down 21.7% After Embracing Rule of 50 Profitability Framework – Has The Bull Case Changed?

Inter & Co, Inc. reported first-quarter 2026 net income of R$394.79 million, up from R$286.59 million a year earlier, with basic and diluted earnings per share from continuing operations rising to R$0.89 from R$0.65. The company also recently adopted the “Rule of 50” as its main framework for balancing growth and return on equity over the next three years, signaling a sharper focus on credit penetration, deposit growth and primary-bank relationships. We’ll now examine how Inter & Co’s shift...
NasdaqGS:SND
NasdaqGS:SNDEnergy Services

Smart Sand (SND) Swings To Q1 Loss Challenging Trailing Profitability Narrative

Smart Sand (SND) opened 2026 with Q1 revenue of US$93.1 million and a reported loss per share of US$0.10, as net income excluding extra items came in at a loss of US$3.9 million. Over the past year, the company has seen quarterly revenue move between US$65.6 million and US$93.1 million, while quarterly EPS has ranged from a loss of US$0.62 to a profit of US$0.55, with trailing twelve month EPS at US$0.56. For investors, the shift to positive earnings on a trailing basis, alongside a soft...
NasdaqGS:TTWO
NasdaqGS:TTWOEntertainment

How Investors May Respond To Take-Two Interactive (TTWO) On UBS Call And GTA VI-Focused Strategy

UBS recently named Take-Two Interactive Software its top pick in the US interactive gaming sector, citing clearer visibility around key franchise releases such as Grand Theft Auto VI and long-term monetization trends, while the company also confirmed CEO Strauss Zelnick’s participation in a TD Cowen technology, media and telecom conference fireside chat later in May 2026. At the same time, Take-Two is reshaping its portfolio by winding down its Private Division indie label, even as GTA...
NasdaqGS:AMGN
NasdaqGS:AMGNBiotechs

A Look At Amgen (AMGN) Valuation After Q1 Beat Guidance Upgrade And US$300 Million US Expansion

Amgen (AMGN) is back in focus after first quarter results showed higher revenue and net income versus a year earlier, along with fresh full year guidance and a new US$300 million US manufacturing investment. See our latest analysis for Amgen. The stock has given investors a 32.3% total shareholder return over the past year, even as the 90 day share price return is down 8.1%. This suggests that earlier momentum has cooled while the latest earnings, guidance and US$300 million manufacturing...